跳至主要内容
临床试验/JPRN-UMIN000041382
JPRN-UMIN000041382招募中未知

Examination of therapeutic efficacy after changing brolucizumab for patients with wet age-related macular degeneration using existing anti-VEGF drugs. - Efficacy of treatment after changing brolucizumab for wet AMD

kagawa university0 个研究点目标入组 100 人开始时间: 2020年8月11日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Greatest Linear Dimension (GLD) of the total lesion area <12 Macular Photocoagulation Study Disc Areas 2) Presence of subretinal hemorrhage, scar or macular fibrosis (>50% lesion area) 3) Prior treatment with dexamethasone (<6 months) or triamcinolone (<30 days), intraocular surgery (<3 months) 4) Active intraocular inflammation 5) Hypersensitivity or allergy to fluorescein or indocyanine green, clinically significant drug allergy or known hypersensitivity to therapeutic or diagnostic protein products 6) Patient who the doctor in charge judges are ineligible for the study

研究者

相似试验